Open AccessAtypical ductal hyperplasia bordering on DCIS on core biopsy is associated with higher risk of upgrade than conventional atypical ductal hyperplasia
Author(s) -
Kate R Pawloski,
Nicole Christian,
Andrea Knežević,
Hannah Y. Wen,
Kimberly J. Van Zee,
Monica Morrow,
Audree B. Tadros
Publication year - 2020
Publication title -
breast cancer research and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.908
H-Index - 154
eISSN - 1573-7217
pISSN - 0167-6806
DOI - 10.1007/s10549-020-05890-1
Subject(s) - ductal carcinoma , medicine , breast cancer , biopsy , upgrade , lobular carcinoma , mammary gland , surgery , cancer , pathology , oncology , operating system , computer science
Upgrade rates of conventional ADH are reported at 10-30%; however, rates for ADH bordering on DCIS (ADH-BD) are largely unknown. We examined the upgrade rate of ADH-BD and core needle biopsy (CNB) features associated with upgrade. Surgical management in patients with concurrent ipsilateral breast cancer (BC) was also examined.